EditCo Bio
Travis Maures is a gene editing specialist currently serving as the Chief Scientific Officer at EditCo since March 2024. Previously, Travis held multiple leadership roles at Synthego Corporation from March 2017 to March 2024, including Chief Technology Officer, Director of Science Research, and Principal Scientist in Functional Biology. Prior experience includes working as Scientist 2 at BioMarin Pharmaceutical Inc. and conducting postdoctoral research at Stanford University and the University of Michigan, focusing on molecular mechanisms of aging and cellular physiology. Academic credentials include a PhD in Cellular and Molecular Biology and a BS in the same field, both obtained from the University of Michigan. Relevant publications include work co-authored with colleagues on significant scientific topics in gene editing and cellular biology.
This person is not in any teams
EditCo Bio
Whatever your edit, we can make it easier with optimized, multi-guide CRISPR kits and made-to-order edited cells. We're dedicated to building a novel research toolkit to make genome engineering simpler and more efficient. EditCo's CRISPR expertise and highly automated manufacturing allows us to engineer a wide variety of cell lines with the speed, consistency, and functionality than can redefine research. Leave CRISPR to us–you focus on discoveries.